The Ministry of the Pharmaceutical Industry speaks about the new measures that can be envisaged in relation to the availability of drugs intended to fight against the symptoms of the coronavirus. We reveal all the information in today’s article on January 23, 2022.
The past few weeks have witnessed a delicate situation on a global scale. Indeed, the balance sheet resulting from the health crisis due to Covid-19 has grown in size. And in all four corners of the world. In particular, on the Algerian territory. That said, the extension of this phenomenon generates a parallel need, including in Algeria, relating to the presence in pharmacies of drugs against the coronavirus.
Indeed, it is about the various treatments designed to successfully treat patients with the virus. As a result, a repercussion is expected in return for the increase recorded in the level of cases tested positive. We are talking here about an excessive demand for anti-covid. This is reported by La patrie news which relays even more details in this regard.
Thus, the source reveals that the Ministry of Pharmaceutical Industry ordered a meeting of the monitoring observatory on the availability of pharmaceutical products. The meeting brought together the various parties involved in the process of supplying drugs to treat the coronavirus. Similarly, said the meeting had as its main mission to remedy any possible shortage of related treatments.
Anti-Covid medication in Algeria: ministerial availability arrangements
First, the ministry has made a digital platform available to participants. Through which, the parties must alert the authority and report any product in excessive demand or out of stock. And even, the level of stocks below the reserve threshold for hospital products.
In addition, the dictated procedures consist of requisitioning the quantities available from suppliers and placing them on the market. In addition, the Ministry has underlined the obligation to inform its competent services of the forecast statements of manufacture, delivery to wholesalers, and distribution to community pharmacists. This is also the case for stock and delivery declarations, indicating the same source.
On the sidelines of the meeting, a statement of forecast reserves by the end of February was drawn up. Thus, the production of paracetamol for sale is estimated at 19 million units. Of which, 6 million at a dosage of 500 mg, while the rest are at a dosage of 1000 mg. On the other hand, 3.3 million units of Enoxaparin are provided (all doses combined). And finally, amoxylin and clavulanic acid with a quantity of 1.3 million units sold. Add the above source.
To conclude, the meeting came out with a directive instruction. This concerns the consolidation of the means and efforts invested in this fight against Covid-19. This is the ultimate desire to maintain the availability of treatments against the coronavirus in pharmacies. And therefore succeed in covering national needs.
